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The labour of the Council of Europe on
Biomedicine
 First step: the Convention for the Protection of Human Rights and Dignity of 
the Human Being with regard to the Application of Biology and Medicine
 Known as Oviedo Convention or Convention on Human Rights and 
Biomedicine (1997, opening for signature; 1999: entry into force)
https://www.coe.int/en/web/bioethics/home
Some preliminary concepts to be 
defined
 Biomedicine: Biomedicine is a branch of medical science that applies
biological and physiological principles to clinical practice. Biomedicine also
can relate to many other categories in health and biological related fields.
It has been the dominant health system for more than a century.
 It includes many biomedical disciplines and areas of specialty that typically
contain the "bio" prefix such as molecular biology, biochemistry, biotechnology,
cell biology, embryology, nanobiotechnology, biological engineering, laboratory
medical biology, cytogenetics, genetics, gene therapy, bioinformatics,
biostatistics, systems biology, neuroscience, microbiology, virology, immunology,
parasitology, physiology, pathology, anatomy, toxicology, and many others that
generally concern life sciences as applied to medicine.
Some preliminary concepts to be 
defined
 Biolaw: Biolaw is a branch of law, emerged as a consequence of the
advance of life sciences, medicine and biotechnology. The traditional basis
of law (at the municipal and international spheres) must be reconsidered,
taking into account the field of human rights, ethics (body and human
dignity), environmental questions, health issues, medical sciences and
surrounded areas. Article on Biolaw
 Bioethics: Bioethics is the study of the ethical issues emerging from 
advances in biology and medicine. It is also moral discernment as it 
relates to medical policy and practice. Bioethics are concerned with the 
ethical questions that arise in the relationships among life sciences, 
biotechnology, medicine and medical ethics, politics, law, and 
philosophy.
COMMON ASPECTS TO BE CONSIDERED (BIOMEDICINE, BIOETHICS AND 
BIOLAW)
• Multidisciplinary approach
• Pluralist study of sciences of life (bio) and technologies, related to human beings
• Changing nature
• Human rights, dignity, biology, medicine, health, ethics and law are intertwined
A group of international instruments…
Number Title Opening of the
Treaty
Entry into force
164 Convention for the protection of 
Human Rights and Dignity of the 
Human Being with regard to the 
Application of Biology and 
Medicine: Convention on 
Human Rights and Biomedicine
04/04/1997 01/12/1999
168 Additional Protocol to the 
Convention, on the 
Prohibition of Cloning 
Human Beings
12/01/1998 01/03/2001
186 Additional Protocol 
concerning Transplantation 
of Organs and Tissues of 
Human Origin
24/01/2002 01/05/2006




203 Additional Protocol 
concerning Genetic Testing 
for Health Purposes
27/11/2008 01/07/2018
The Oviedo Convention: two
official languages (English and
French)
Together with unofficial translations: 
Czech – Dutch – Estonian – Finnish – Georgian – German –
Hungarian – Icelandic – Italian – Latvian – Lithuanian – Polish –
Romanian – Russian and Explanatory Report – Slovak –
Slovenian – Spanish and Corrective – Ukrainian
With great impact in the field
of Human Rights
Bioethical issues concern us all, as patients or professionals, but also as members of a 
society facing new choices as a result of scientific progress. 
What are the principles on which we all need to agree? 
What framework do we need to establish to prevent abuses and promote advances that 
are of benefit to humankind?
• Can I refuse to undergo a genetic test requested by a future employer or my 
insurance company?
• What information should a doctor provide to a person suffering from an illness who 
wishes to take part in a clinical trial for a new medicine?
• Can samples taken from a person during treatment be used for research purposes?
• Is it possible for me to use medically assisted procreation techniques to choose the 
gender of my child?
• If an examination on a patient brings to light information that is relevant to the health 
of other family members, should they be informed accordingly?
• Do I have the right to sell one of my kidneys, or my sperm or ova?
First step: the Oviedo Convention in a 
few words
 The first legally-binding international text designed to preserve human dignity,
rights and freedoms, through a series of principles and prohibitions against the
misuse of biological and medical advances.
 Starting point: the interests of human beings must come before the interests of
science and society.
 The Convention recognises the importance of promoting a public debate and
consultation on these questions.
 The only restrictions are those prescribed by law and which are necessary in a
democratic society in the interest of public safety, for the prevention of crime,
for the protection of public health or for the protection of the rights and
freedoms of others.
 Additional Protocols are foreseen to clarify, strengthen and supplement the
overall Convention.
 The Steering Committee on Bioethics (CDBI), or any other committee
designated by the Committee of Ministers of the Parties may request the ECHR
to give advisory opinions on legal questions concerning the interpretation of the
Convention.
State Parties to the Convention
 On 2017 celebrated the 20th Anniversary.
 States Parties: Full-list
 Some significant absences: Austria, Belgium, Germany, Ireland, Italy,
Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Poland, the
Russian Federation, Sweden, Ukraine or the United Kingdom.
 Followed by some reservations and declarations: See (most of them
referred to article 20, par.2, sub-paragraph ii, concerning the removal of
regenerative tissue and the limitations of the Convention to certain
categories of relatives).
Main goals of the Oviedo Convention
 Primacy of the human being (prevailing over the sole interest of society or
science).
 Free and informed consent (to carry out an intervention in the health field).
 Appropriate information as to the purpose and nature of the intervention, its
consequences and risks. 
 The person concerned may freely withdraw consent at any time.
 Arts. 6 and 7 deals with the protection of persons not able to consent and 
protection of persons who have a mental disorder. Emergency situations (art. 8) 
and previously expressed wishes shall be taken into account (art. 9).
Main goals of the Oviedo Convention
(II)
 Private life and right to information (art. 10), including the right to be/not to 
be informed.
 The human genome issues (non-discrimination, predictive genetic tests, 
intervention on the human genome, and non-selection of sex).
 And scientific research together with protection of persons undergoing
research, and research on embryos in vitro.
 Organ and tissue removal from living donors for transplantation purposes
and, in particular, protection of persons not able to consent to organ
removal (RESERVATIONS TO ART. 20, par.2, ii).
 The prohibition of financial gain and disposal of a part of the human body
are aspects to be considered. 
An open and unfinished text…
 Open for signature by the member States of the Council of Europe, the
non-member States which have participated in its elaboration and by the
EU (European Community when the Oviedo Convention was
adopted).Council of Europe member States
 After the entry into force, there is a possibility to invite any non-member
State of the Council of Europe to accede to this Convention (art. 34). 
Followed by some Additional
Protocols..
 1. On the Prohibition of Cloning Human Beings (Paris, 12/01/1998, entered
into force the 01/03/2001).See
 The first legal instrument developed in this area. State parties
 The cloning of human beings may become a technical possibility.
 A question to be answered: what is a human being? Example: the
declaration from the Netherlands (at the time of signature). A human being
is a human individual (who has been born).
 The Protocol explicitly restricts genetic identity to sharing the same nuclear
gene set, meaning that any intervention by embryo splitting or nuclear
transfer techniques seeking to create a human being genetically identical
to another human being, whether living or dead, is prohibited.
Followed by some Additional Protocols
(II)
 2. Additional Protocol concerning Transplantation of Organs and Tissues of
Human Origin.See
 Adopted in Strasbourg the 24 of January 2002. Entered into force the 1 of May
2006. In Spain the 1st April 2015 (ratified in 2014). State Parties
 It contains specific provisions regarding the transplantation of organs and tissues
(including cells) of human origin for therapeutic purposes, and the promotion of
donation of organs and tissues
 It includes equitable access to transplantation services for patients, transparent
rules for organ allocation, health and safety standars, the prohibition of financial
gain by donors, and the need for donors, recipients, health professionals and
the public to be properly informed.
 Some additional aspects: tissues shall be allocated only among patients on an
oficial waiting list (transparency principle) and traceability of organs and tissues
must be ensured.
Followed by Additional Protocols (III)
 3. Additional Protocol concerning Biomedical Research.See
 Strasbourg, 25 of January 2005, entered into force the 1st September 2007. State
Parties
 Define and safeguard fundamental rights in biomedical research, in particular
of those participating in research.
 Fundamental principle for research involving human beings: free, informed,
express, specific and documented consent of the person(s) participating.
Followed by Additional Protocols (IV)
 Concerning Genetic Testing for Health Purposes.See
 Strasbourg, 27 November 2011, entered into force the 1st July 2018. State
Parties
 Genetic tests (general rules to conduct them), directly accesible genetic
tests for which a comercial offer could develop in future. 



















The “right not to be informed” in the 
Biomedicine Convention and the Additional 
Protocols: Some initial remarks
A key point…
 The relationship between ethics, science and freedom (new frontiers of the 
Science, new dimensions for human rights)
 International instruments: declaratory instruments and international 
conventions (in the sphere of the Council of Europe).
From the Aristotelic view to biomedicine 
recent contributions…
 The right not to know, and the need to take into account this idea:
contributions of the Council of Europe, the UNESCO, the WHO and the
European Union…
To begin with it…as a departure point, Recommendation R (90) 
3 of the Committee of Ministers of the Council of Europe 1990:
Principle 3
 1. No medical research may be carried out without the informed, free, express and
specific consent of the person undergoing it. Such consent may be freely withdrawn
at any phase of the research and the person undergoing the research should be
informed, before being included in it, of his right to withdraw his consent.
 2. The person who is to undergo medical research should be given
information on the purpose of the research and the methodology of the
experimentation. He should also be informed of the foreseeable risks
and inconveniences to him of the proposed research. This information
should be sufficiently clear and suitably adapted to enable consent to
be given or refused in full knowledge of the relevant facts. (Emphasis
added)
 3. The provisions of this principle should apply also to a legal representative and to a
legally incapacitated person having the capacity of understanding, in the situations
described in Principles 4 and 5.
Followed by different declarations at 
the international sphere…
 Art. 5 c) of the UNESCO Universal Declaration on the Human Genome and 
Human Rights (1997) (Text)
 Art. 10 of the UNESCO International Declaration on Human Genetic Data 
(2003) (Text)
 Together with the work of the World Medical Association (Declaration of 
Lisbon on the Rights of the Patient) and the WHO 
The “real right”: full, understandable 
information. What does it mean?
 Art. 5 of the Biomedicine Convention and art. 8 of the Additional Protocol 
concerning Genetic Testing for Health Purposes:  
 “When a genetic test is envisaged, the person concerned shall be provided with 
prior appropriate information in particular on the purpose and the nature of the 
test, as well as the implications of its results” (emphasis added). 
Art. 5 of the Biomedicine Convention
 “(…)an intervention in the health field may only be
carried out after the person concerned has given free
and informed consent to it.
 This person shall beforehand be given appropriate
information as to the purpose and nature of the
intervention as well as on its consequences and risks.
 The person concerned may freely withdraw consent at
any time”.
Relevant step: art. 10 of the Oviedo 
Convention…
 Article 10 –Private life and right to information
1. Everyone has the right to respect for private life in relation to
information about his or her health.
2. Everyone is entitled to know any information
collected about his or her health. However, the wishes
of individuals not to be so informed shall be observed.
3. In exceptional cases, restrictions may be placed by law on
the exercise of the rights contained in paragraph 2 in the interests
of the patient.
«la volontà di una persona di non essere 
informata deve essere rispettata»; «droit de 
ne pas savoir» «right not to know»
…that is strongly emerging in the field 
of biomedical research and genetics
 In particular, being included in the Additional Protocol
concerning Genetic Testing for Health Purposes, of 27
November 2008 (art. 16).
 Or in art. 27 (Duty of care) of the Additional Protocol
concerning Biomedical Research, of 25 January 2005. (In
communication of such information, due care must be taken
in order to protect confidentiality and to respect any wish of
the participant not to receive such information).
Article 16 of the Protocol on Genetic 
Testing
 Article 16 – Respect for private life and right to information 
1.Everyone has the right to respect for his or her private life, in
particular to protection of his or her personal data derived from a genetic
test.
2.Everyone undergoing a genetic test is entitled to know any
information collected about his or her health derived from this test.
The conclusions drawn from the test shall be accessible to the person
concerned in a comprehensible form.
3.The wish of a person not to be informed shall be
respected.
4.In exceptional cases, restrictions may be placed by law on the
exercise of the rights contained in paragraphs 2 and 3 above in the
interests of the person concerned.
A right connected with the right to be 
informed and submitted to limitations
 Limited by the “health of the patient, of third persons, the collectivity and
the therapeutic needs of the case”
 The delegation to the respective internal laws of the exercise and
limitations of this right.
A relevant limit…
 …the right not to be informed is not presumed: it must be “activated” in an 
explicit way by the person who tries to exercise it. Is this more a “right” 
stricto sensu, or just a possibility connected with free autonomy? 
Development of this “right” by 
municipal law in Spain
 Firstly, in general acts, being applied in the State as a whole:
 Basic Act 41/2002, of 14 November, on free autonomy of the patient and rights 
and duties concerning information and clinic documentation (art. 9).Text
 Act 14/2007, of 3 July on Biomedical Research (art. 4.5 in fine and art. 49.2).Text
Basic Act on free autonomy of the
patient, art. 5.4 (theraupetic needs)
 “The right to sanitary information of the patients may be limited by
the accredited existence of a situation of therapeutic needs. A
therapeutic need will be understood as the possibility of the doctor
to act in a professional way without giving the information to the
patient, in case of, due to objective reasons, the knowledge of his
own situation could produce a serious prejudice to his health. If it is
the case, the doctor will explain in a reasoned and formal way of
the clinic history circumstances and will communicate his decision
to the persons connected with the patient by familiar or factual
reasons”.
Basic Act on free autonomy of the 
patient, art. 9.1 (limits)
 This provision says:
 “The waiver of the patient to receive information is limited by
the health of the patient, of third persons, the collective and
the therapeutic needs of the case. When the patient will
express his desire not to be informed, his wish will be
respected, and it must be expressed in a documentary way,
without prejudice of the need to obtain his consent before
the intervention.”
Spanish Act 14/2007, of 3 July on  
Biomedical Research
 Art. 49.2: 
 “When the person concerned have exercised the right not to
be informed of the results of a genetic analysis, he will receive
just the necessary information in order to follow the doctor’s
prescription and accepted by the patient. When this
information is necessary to avoid a relevant prejudice for the
health of biological relatives, the affected persons or legal
authorized representatives could be informed. Anyway, the
communication will be exclusively limited to the necessary
data to obtain the mentioned result”.
This is the general view, completed by a great number of 
municipal laws of the Autonomous Communities, dealing with 
rights and duties of the health system users
 Act 21/2000, of 29 December, on rights of information on the health and 
the autonomy of the patient and clinic documentation, of the Autonomous 
Community of Catalonia, as amended by Act 16/2010, of 3 June.Text
 Act 11/2007, of 26 November, on the Genetic Council, protection of rights
of persons submitted to genetic tests and human DNA Banks of
Andalusia.Text
Together with…
 Act 3/2009, of 11 May, on rights and duties of users of the health system of 
the Autonomous Community of Murcia.
 Foral Act 17/2010, of 8 November, of the Foral Community of Navarra on 
rights and duties of persons dealing with health matters. 
With recent rules on rights and guarantees 
of person’s dignity in death throes
 Merely as examples of some laws adopted on this field: Act 2/2010, of 8
April, of the Autonomous Community of Andalusia (BOE n. 127, 25 May
2010), the Foral Act 8/2011, of 24 March of the Foral Community of Navarra
(BOE n. 99, of 26 April 2011), or the Act 10/2011, of 24 March, of the
Autonomous Community of Aragón (BOE n. 115, of 14 May 2011).
And opening the door to initial 
conclusions…
 The discussion between the “right not to be informed”: 
an open question.
 This new debate try to have an answer in the most 
recent municipal legislation in Spain, following the 
international standards.
 An open question, because not all the Autonomous 
Communities have developed this topic. 
Related Instruments of the Council of 
Europe under review
 Rec (2016) 8 on the processing of personal health-related data for
insurance purpose, including data resulting from genetic tests
 Rec (2016) 6 on Research on Biological Materials of Human Origin
 Rec (2004) 10 concerning the Protection of the Human Rights and Dignity of
Persons with Mental Disorder
 Rec (2003) 10 on Xenotransplantation
• Surrogacy, 
• assisted reproductive techniques, 
• the end of life issues, 
• genetic engineering, 
• the use of vaccines, 
• organ trafficking, 
• pandemics, 
• new diseases, 
• new medical treatments (….)
When Science, Human Rights and Law are intertwinned…
Together with Legal 
challenges and new 
technologies
• Big data
• the development of artificial 
intelligence in unexplored areas,
• robotics development, ….





Tentative conclusions: a long way to 
go… 
 Opinion of the Judge Marcus-Helmons (Cyprus v. Turkey case, 10 May 2001, 
application 25781/94):
 “With the rapid evolution of biomedical techniques, new threats to human
dignity may arise. The Convention on Human Rights and Biomedicine, signed at
Oviedo in 1997, seeks to cover some of those dangers. However, to date only a
limited number of States have signed it. Moreover, this Convention only affords
the European Court of Human Rights consultative jurisdiction. In order this “fourth
generation rights” to be taken into account so that human dignity is protected
against possible abuse by scientific progress, the Court could issue a reminder
that under Article 2 of the European Convention on Human Rights the States
undertook to protect everyone’s right to life by law”.
“Science without conscience is but the ruin of the soul”
Rabelais
